EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

An aging-related gene signature, featuring Cdkn2a, predicts prognosis and immunotherapy response in uterine corpus endometrial carcinoma

Aying Liu, Yuchuan Shi, Yu He, Wenjing Zhu, Lei Zhan, Kang Shao

Discover Oncology · 14.03.2026 · 17 (1)

DOI: 10.1007/s12672-026-04795-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 14.03.2026. Verfasst von Aying Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Scientific Research of the First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Hefei, 230022, Anhui, China. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Research Fund of Anhui Institute of Translational Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Aging-related biomarkerCdkn2aCellular senescenceImmune therapyUterine corpus endometrial carcinoma (UCEC)

Autor:innen und Institutionen

  • The Center for Scientific Research of the First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Hefei, 230022, Anhui, China.
  • Department of Obstetrics and Gynecology, The Second Hospital of Anhui Medical University, No. 678 Furong Road, Hefei, 230601, Anhui, China.
  • Department of Obstetrics and Gynecology, Lu'an Hospital of Anhui Medical University, No. 21 Wanxi West Road, Lu'an, 237005, Anhui, China.
  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Hefei, 230022, Anhui, China. m1351565@163.com.
  • Department of Obstetrics and Gynecology, The Second Hospital of Anhui Medical University, No. 678 Furong Road, Hefei, 230601, Anhui, China. sk492716yt@163.com.

Förderung

  • Research Fund of Anhui Institute of Translational Medicine

Zitieren

APA

Liu, A., Shi, Y., He, Y., Zhu, W., Zhan, L., & Shao, K. (2026). An aging-related gene signature, featuring Cdkn2a, predicts prognosis and immunotherapy response in uterine corpus endometrial carcinoma. Discover Oncology, 17(1). https://doi.org/10.1007/s12672-026-04795-7

Vancouver

Liu A, Shi Y, He Y, Zhu W, Zhan L, Shao K. An aging-related gene signature, featuring Cdkn2a, predicts prognosis and immunotherapy response in uterine corpus endometrial carcinoma. Discover Oncology. 2026;17(1). doi:10.1007/s12672-026-04795-7

BibTeX
@article{Liu2026,
  author = {Liu, Aying and Shi, Yuchuan and He, Yu and Zhu, Wenjing and Zhan, Lei and Shao, Kang},
  title = {An aging-related gene signature, featuring Cdkn2a, predicts prognosis and immunotherapy response in uterine corpus endometrial carcinoma},
  journal = {Discover Oncology},
  year = {2026},
  volume = {17},
  number = {1},
  doi = {10.1007/s12672-026-04795-7}
}
Kostenlos starten →